Michael Seidman joins Fox Chase Department of Hematology/Oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Michael Seidman

Michael Seidman has joined Fox Chase Cancer Center as a professor in the Department of Hematology/Oncology.

Seidman is joining Fox Chase after spending over 15 years at Alliance Cancer Specialists in Horsham, PA, where he provided care to patients with a wide array of hematologic and oncologic disorders, assisted in the development of a new radiation oncology center, and participated in clinical trials. He also served as a board member of Alliance Cancer Specialists and managing partner of the Abington Division.

Seidman was on the medical staff of Chestnut Hill Hospital, Holy Redeemer Medical Center, and Jefferson Abington Hospital. Also, he served on the Cancer Committee for Holy Redeemer and Jefferson Abington, where he was a member of the Medical Executive Committee.

Seidman received his medical degree from the Lewis Katz School of Medicine at Temple University. He completed an internal medicine residency at Temple University Hospital, followed by an oncology fellowship at New York University Medical Center. While at NYU, he was named Hematology/Oncology Chief Fellow and Oncology Fellow of the Year.

Seidman has a number of professional publications and presentations to his credit, and some of his presentations were delivered in Barcelona at the First World Meeting of Interdisciplinary Melanoma Centers. He is board certified in hematology and medical oncology.

Table of Contents

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

Login